Effective suppression of parathyroid hormone by 1α-hydroxy-vitamin D2 in hemodialysis patients with moderate to severe secondary hyperparathyroidism

The spectrum of bone disease in end-stage renal failure—An evolving disorder

Donald J. Sherrard, Gavril Hercz, York Pei et al. · Kidney International · 1993 · 736 citations

Glomerular Disease, Glomerulonephritis, Hemodialysis +13

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Eduardo Slatopolsky, Carol Weerts, J Thielan et al. · Journal of Clinical Investigation · 1984 · 686 citations · Full text

Secondary Hyperparathyroidism, Marked Suppression, Serum Calcium +13

Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells.

J. Silver, Jean E. Russell, Louis M. Sherwood · Proceedings of the National Academy of Sciences · 1985 · 497 citations

Animal Physiology, Messenger Ribonucleic Acid, Vitamin D Metabolites +15

Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal Failure

D L Andress, Keith C. Norris, J. W. Coburn et al. · New England Journal of Medicine · 1989 · 323 citations

Refractory Osteitis Fibrosa, Hemodialysis, Urology +14

Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia.

L. Darryl Quarles, Bruce Lobaugh, G. Murphy · The Journal of Clinical Endocrinology & Metabolism · 1992 · 288 citations

Urology, Body Composition, Medicine +15